ATS PI-TB Assembly

Oelofse et al. studied linezolid rechallenge among participants with rifampicin resistant TB in an observational cohort study #TB thelancet.com/journals/langl…

Recently, a publication by Moe et al. in Clinical Infectious Disease found non-inferiority between tongue swab vs. sputum based molecular testing for TB. #tuberculosis, #clinicalinfectiousdisease academic.oup.com/cid/advance-ar…

New publications studyin the impact of funding cuts to low and middle income countries and progress for TB treatment and eradication. #tuberculosis #pulmonary #medicine journals.plos.org/plosmedicine/a…

❄️🗞️ The PITB Highlights Winter Newsletter is here! Get an inside look at what our members are excited about at #ATS2026, catch up on the latest articles, and check out the return of the Vaccine and Immunization Advisory Group 🫁 @ATS_Assemblies @atscommunity

Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline @ATS_PITB @atscommunity 🔓 Open Access 🔗 tinyurl.com/yckaz5dn

Wang and colleagues used bronchoalveolar lavage to study the lung microbiome of severe and non-severe pneumonia in a multi-centre study from China. Here the authors discuss a depletion of oral commensals that is associated with more severe pneumonia. rdcu.be/e4JDT

Drs. Green, Devarajan, Swenson, Losier, and Gu discuss non-cystic #bronchiectasis emphasising the importance of mucus, from biochemical properties to clinical practice. A must view for those interested in #bronchiectasis research. #Chest #ATS chestnet.org/guidelines-and…

Associated secondary analysis here: Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trial - eClinicalMedicine thelancet.com/journals/eclin…

🔥🔥🔥 HOT OF THE PRESS!🔥🔥🔥 Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial - The Lancet Infectious Diseases thelancet.com/journals/lanin…

🚨Don’t miss the deadline—vote now for your Assembly leaders! site.thoracic.org/membership/ass…

This retrospective cohort study assessed nirmatrelvir–ritonavir (NMVr) effectiveness in severe COVID-19 using real-world data. 🦠🧫 Results showed NMVr therapy was associated with lower risks of intubation and in-hospital mortality. link.springer.com/article/10.118…

A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia | American Journal of Respiratory and Critical Care Medicine atsjournals.org/doi/full/10.11…

Hein et al. investigated the association between vitamin D status and mortality in patients hospitalized with CAP 💊🫁 Results suggested a higher risk of 90- and 180-day mortality among those with vitamin D deficiency. academic.oup.com/ofid/article/1…

Bronchiectasis Education Center: Ask the Expert with Anne O’Donnell, MD Join leading expert, Ashley Losier, MD, from Yale University, for an interactive “Ask the Expert” session at 1 p.m. ET on January 28, 2026. Registration is required and is free – ow.ly/TwU150XWGET

🫁Sensitization to recombinant Aspergillus fumigatus (rAsp f) is a key trait in bronchiectasis. This multicenter study across four countries links rAsp f allergen responses to severe exacerbations, especially in those with <3 events/year. #CHESTjournal journal.chestnet.org/article/S0012-…

🧫 ENIRRI secondary analysis of 1,059 ICU patients with nosocomial respiratory infections, P. aeruginosa accounted for 14.5% of cases and was strongly associated with COPD GOLD D, autoimmune disease, chronic kidney disease, and early acute kidney injury.🫁buff.ly/HuqtpoR

🧪Meet our @ATS_PITB Assembly Early Career Highlight, Dr. Ian Galbreath, MD!🔬 Dr. Galbreath's research has focused on early life viral infections 🦠 and development of asthma. 🧫 When he is not seeing patients, he is an avid runner! 🏃 🥼

🫁Latest in implementation science, mHealth for TB + smokers: Cluster RCT in Pakistan (n=1080) found daily→monthly text messages tripled biochemically confirmed 6‑mo abstinence (41.7% vs 15.3%; RR≈3.0) without harming TB outcomes!📱 jamanetwork.com/journals/jama/…

New in Nature Medicine: Modeling of 6.8M TB notifications from 111 LMICs shows that scaling up PCR-based diagnostics mainly reduces missed TB (false negatives), but has a much smaller impact on false-positive diagnoses driven by clinical judgment alone.